禾信仪器选举第四届董事会董事长，聘任徐向东为总经理

Core Viewpoint - The article discusses the recent changes in the management and board of directors of Guangzhou Hexin Instrument Co., Ltd., including the election of a new chairman and the appointment of senior management personnel, amidst ongoing financial challenges faced by the company [1][2]. Board of Directors Election - On May 22, 2025, the company held its first meeting of the fourth board of directors, where it unanimously elected Mr. Zhou Zhen as the chairman of the board, with his term lasting until the end of the current board's term [4]. Special Committee Elections - During the same meeting, the company elected members and conveners for its special committees, including: - Audit Committee: Chaired by Chen Ming, with members Chen Ming, Zhou Zhen, and Liu Qiliang - Nomination Committee: Chaired by Liu Qiliang, with members Liu Qiliang, Kong Yunfei, and Zhou Zhen - Compensation and Assessment Committee: Chaired by Liu Qiliang, with members Liu Qiliang, Kong Yunfei, and Zhou Zhen - Strategic Development Committee: Chaired by Zhou Zhen, with members Zhou Zhen, Xu Xiangdong, and Liu Qiliang [6]. Senior Management Appointments - The board also approved the appointment of new senior management personnel: - Xu Xiangdong as General Manager - Sun Jiande as Chief Financial Officer - Lu Wanli as Secretary of the Board These appointments are effective from the date of the board's approval until the end of the current board's term [9]. Management Changes - The company has experienced multiple changes in its executive team since 2024, including the departure of several key executives, which may indicate instability within the management structure [11][20]. Financial Performance - In 2024, the company reported a significant decline in revenue, with total revenue of 203 million yuan, a decrease of 44.70% year-on-year. The net profit attributable to shareholders was a loss of approximately 46 million yuan, marking three consecutive years of losses, with total losses exceeding 200 million yuan [21][22]. - The company's R&D expenses also saw a substantial reduction of 51.44%, with R&D investment amounting to approximately 33 million yuan, representing only 16.20% of total revenue [22][23].